Lymphatic System Cancer
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Human B-Cell CLL/Lymphoma 10 (Bcl10) | Login | Recombinant Human B-Cell CLL/Lymphoma 10 (Bcl10) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse B-Cell CLL/Lymphoma 10 (Bcl10) | Login | Recombinant Mouse B-Cell CLL/Lymphoma 10 (Bcl10) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Receptor Activator Of Nuclear Factor Kappa B (RANk) | Login | Recombinant Mouse Receptor Activator Of Nuclear Factor Kappa B (RANk) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | Login | Recombinant Human Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Rat Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | Login | Recombinant Rat Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Receptor Activator Of Nuclear Factor Kappa B (RANk) | Login | Recombinant Human Receptor Activator Of Nuclear Factor Kappa B (RANk) | ||||||||||||||||
|
||||||||||||||||||
| Human beta-2-Microglobulin (B2M) Antibody | Login | Human beta-2-Microglobulin (B2M) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Mouse beta-2-Microglobulin (B2M) Antibody | Login | Mouse beta-2-Microglobulin (B2M) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Rat beta-2-Microglobulin (B2M) Antibody | Login | Rat beta-2-Microglobulin (B2M) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | Login | Human beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Rat beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | Login | Rat beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Mouse beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | Login | Mouse beta-2-Microglobulin (B2M) Antibody (Biotin Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP Antibody | Login | Human FDCSP Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP Antibody (Biotin Conjugate) | Login | Human FDCSP Antibody (Biotin Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP AssayLite™ Antibody (APC Conjugate) | Login | Human FDCSP AssayLite™ Antibody (APC Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP AssayLite™ Antibody (FITC Conjugate) | Login | Human FDCSP AssayLite™ Antibody (FITC Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP AssayLite™ Antibody (PerCP Conjugate) | Login | Human FDCSP AssayLite™ Antibody (PerCP Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human FDCSP AssayLite™ Antibody (RPE Conjugate) | Login | Human FDCSP AssayLite™ Antibody (RPE Conjugate) | ||||||||||||||||
|
||||||||||||||||||
| Human Prealbumin (Transthyretin, TTR) AssayMax™ ELISA Kit | Login | Human Prealbumin (Transthyretin, TTR) AssayMax™ ELISA Kit | ||||||||||||||||
|
||||||||||||||||||
| Human beta-2-Microglobulin (B2M) AssayMax™ ELISA Kit | Login | Human beta-2-Microglobulin (B2M) AssayMax™ ELISA Kit | ||||||||||||||||
|
||||||||||||||||||
| Human Apolipoprotein B (Apo B) AssayMax™ ELISA Kit | Login | Human Apolipoprotein B (Apo B) AssayMax™ ELISA Kit | ||||||||||||||||
|
||||||||||||||||||
| Human Complement C4 AssayMax™ ELISA Kit | Login | Human Complement C4 AssayMax™ ELISA Kit | ||||||||||||||||
|
||||||||||||||||||
| Human Complement C4 AssayMax™ ELISA Kit | Login | Human Complement C4 AssayMax™ ELISA Kit | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Tumor necrosis factor ligand superfamily member 11 (Tnfsf11), partial | Login | Recombinant Mouse Tumor necrosis factor ligand superfamily member 11 (Tnfsf11), partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human B-cell lymphoma/leukemia 10 (BCL10) | Login | Recombinant Human B-cell lymphoma/leukemia 10 (BCL10) | ||||||||||||||||
|
||||||||||||||||||


